SAHPRA is tasked with regulating (monitoring, evaluating, investigating, inspecting and registering) all health products and clinical trials in South Africa.
South Africa
Joined November 2019
- Tweets3.9K
- Following228
- Followers9.5K
- Likes135
The countdown to #MedSafetyWeek 2026 is on!
Healthcare professionals, patients, caregivers and healthcare organisations all have a role to play in medicines safety.
Together, we can raise awareness about reporting suspected side effects and help make medicines safer for everyone.
Visit the Med Safety App website to learn more about reporting adverse drug reactions: 🔗 bit.ly/317oReA
No single regulator can address Africa’s health product challenges alone.
At #AMAWeek in Kigali, SAHPRA CEO Dr @Tumisemete emphasised the value of regulatory collaboration across the continent.
@AU_AMA_ offers an opportunity to strengthen regulatory systems, reduce duplication and support timely access to safe, quality-assured medicines—so patients can benefit from stronger safeguards and improved access to essential health products.
In her keynote, @SAHPRA1 CEO Dr Boitumelo Semete Makokotlela outlined how reliance became a route to access during the pandemic and beyond. She also shared a set of questions to guide the conversation over the next few days including :
1. Do we share a common understanding of reliance? Does have the same understanding of “sameness”?
2. Are regulators able to get full access to dossiers and reports they rely on?
3. How are the 10 ML3 countries progressing in relying on each other?
SAHPRA retweeted
In her keynote, @SAHPRA1 CEO Dr Boitumelo Semete Makokotlela outlined how reliance became a route to access during the pandemic and beyond. She also shared a set of questions to guide the conversation over the next few days including :
1. Do we share a common understanding of reliance? Does have the same understanding of “sameness”?
2. Are regulators able to get full access to dossiers and reports they rely on?
3. How are the 10 ML3 countries progressing in relying on each other?
Africa’s health security depends on strong, agile and collaborative regulatory systems.
At the #AMAWeek in Kigali, SAHPRA CEO Dr @Tumisemete highlighted the importance of strengthening medicines regulation to safeguard patients and support timely access to safe, quality and effective health products.
Through the African Medicines Agency, regulatory collaboration can help patients benefit from more consistent oversight, faster regulatory processes and greater access to quality-assured medical products.
ALT SAHPRA CEO, Dr Boitumelo Semete-Makokotlela presenting at #AMAWeek in Kigali
At #AMAWeek in Kigali, DG Dr Delese Mimi Darko met the Heads of African NRAs. They discussed how their Network should work, AMA Treaty ratification and deeper cooperation.
Read her reflections: lnkd.in/p/dR7Nz7Xj
Career Opportunity: Medicine Control Officer
The South African Health Products Regulatory Authority (SAHPRA) invites applications for the position of Medicine Control Officer.
📅 Closing date: 10 November 2026
🔗 Find out more and apply: bit.ly/41uX9Uk
Take the next step in your career and join SAHPRA in safeguarding public health!
#SAHPRA #CareerOpportunities #ApplyNow
Stakeholder engagement advanced discussions on South Africa’s clinical trial ecosystem.
Medical Directors, Clinical Research Organisations, academic institutions and Health Research Ethics Committees contributed to discussions on strengthening clinical trials and supporting effective regulatory decision-making.
SAHPRA plays a critical role in ensuring clinical trials meet regulatory requirements for safety, quality and ethical conduct before new medicines can be considered for approval, helping protect participants while supporting research and innovation.
#ClinicalTrials #PatientSafety #ResearchEthics #SAHPRA
Responsible regulation, stronger research, better outcomes for patients.
SAHPRA’s Clinical Trials Committee is engaging industry, academia and Health Research Ethics Committees to strengthen regulatory understanding, promote compliance and support ethical, scientifically sound clinical trials. These engagements help protect participants, build confidence in research and support the development of safe, effective health products for patients in South Africa.
#ClinicalTrials #SAHPRA #ResearchExcellence
ALT SAHPRA Clinical Trials Manager, Kedibone Malatjie, engaging Industry representatives at the Clinical Trials Committee workshop.
ALT Participants at the Clinical Trials Committee workshop
Science careers go beyond the laboratory.
SAHPRA recently engaged students at @theNWU SPCS in Action Career Days, highlighting opportunities in radiation science, regulatory science and public health protection.
Read more: bit.ly/47uKHHW
#SAHPRA #MyNWU #SPCSInAction
ALT SAHPRA representatives at the North-West University’s SPCS In Action Career Days, 29-30 September 2026, North-West University, Mafikeng Campus
SAHPRA retweeted
#WEBINAR: CPD Points
Hosted by Knowledge Hub
Title: Climate Change and Health: El Nino Preparedness and Response
Date: 22 October 2026
Time: 10am - 12pm
Theme: Strengthening Public Health Response toward the impacts of El Nino
#SaveTheDate
📢 Re-advertisement: Business Analyst – SAHPRA
The South African Health Products Regulatory Authority (SAHPRA) invites applications for the position of Business Analyst on a 5-year fixed-term contract.
🔗 Find out more and apply: bit.ly/41uX9Uk
📅 Closing date: 30 October 2026 at 16:00
Don't miss this opportunity to join SAHPRA!
#SAHPRA #CareerOpportunities #ApplyNow
At the #SAPCConference, SAHPRA CEO Dr @Tumisemete moderated a discussion on codeine, cannabis, stress management and GLP-1 medicines for weight management.
With the growing misuse of codeine and risks posed by falsified and illegally supplied GLP-1 products, SAHPRA continues to strengthen regulatory oversight to protect patients.
Responsible medicine use starts with informed choices!
#PatientSafety #SAHPRA #SAPCconference
ALT SAHPRA CEO Dr @Tumisemete, moderating a discussion on codeine, cannabis, stress management and GLP-1 medicines for weight management.
ALT SAHPRA CEO Dr @Tumisemete, moderating a discussion on codeine, cannabis, stress management and GLP-1 medicines for weight management.
ALT SAHPRA colleagues at the SAPC Conference.
ALT SAHPRA CEO Dr @Tumisemete, engaging the crowd at the SAPC Conference.
Better medicine safety starts with you!
At the @OfficialSAPC Conference in Durban, SAHPRA’s Pharmacovigilance and Section 21 teams are on standby to answer your questions and demonstrate how to use the #MedSafetyApp to report suspected side effects. Visit our stand, get informed and discover how you can help make medicines safer for everyone. Every report matters!
#SAPCConference #SAHPRA #PatientSafety
ALT SAHPRA’s Pharmacovigilance and Section 21 teams engaging visitors at the exhibition stand
ALT SAHPRA’s Pharmacovigilance and Section 21 teams engaging visitors at the exhibition stand
SAHPRA retweeted
World Arthritis Day is commemorated annually on 12 October to raise awareness about arthritis and other rheumatic and musculoskeletal diseases. The theme, “Achieve Your Dreams,” highlights the importance of early diagnosis, care and support to help people live fulfilling lives.
Behind every medicine is a patient who deserves confidence in its safety, quality and efficacy.
At the @OfficialSAPC Conference in Durban, SAHPRA is connecting with pharmacists and other healthcare professionals to strengthen collaboration, support informed decisions and keep patients at the centre of health product regulation.
#PatientSafety #SAHPRA #SAPCConference
ALT SAHPRA staff connecting with pharmacists and other healthcare professionals at the 4th National Pharmacy Conference
ALT SAHPRA staff connecting with pharmacists and other healthcare professionals at the 4th National Pharmacy Conference.
ALT SAHPRA staff connecting with pharmacists and other healthcare professionals at the 4th National Pharmacy Conference.
📢 SAHPRA Learnership Opportunities!
The South African Health Products Regulatory Authority (SAHPRA) invites applications for the Business Administration Learnership Programme.
This 12-month learnership includes fully funded theoretical training provided by an accredited training provider, combined with workplace-based experience. Learners will receive a monthly stipend to support them during the programme.
🎓 Qualification: Further Education and Training Certificate – Business Administration (NQF Level 4)
🗓 Closing date: 23 October 2026 at 16:00
🔗 Find out more and apply: bit.ly/41uX9Uk
Take the next step towards building your career with SAHPRA!
#SAHPRA #Learnership #CareerOpportunities #ApplyNow
Day 3 at #WHX2026! 🇿🇦
The SAHPRA team is at our exhibition stand engaging with healthcare professionals & industry leaders on health product regulation.
Today, Khomotso Maredi & Neo Monaheng from our Medical Devices Unit are sharing insights on medical device safety & public health protection.
Thanks to everyone who has visited us so far!
#SAHPRA #MedicalDevices #PublicHealth
ALT SAHPRA engages healthcare professionals, industry partners, and visitors at our exhibition stand.
